Investing in pharmaceutical stocks

Being a sector that is always in demand, pharmaceutical stocks also have the potential for long-term growth. As populations age and healthcare needs continue to rise, demand for innovative drugs and treatments is expected to increase. This presents a significant opportunity for pharmaceutical companies to develop new solutions and generate substantial revenue, benefiting those in need of medicine and potentially shareholders.

Understanding the pharmaceutical sector

The pharmaceutical sector is a dynamic industry that plays a crucial role in our society. It includes companies involved in the research, development, manufacturing and marketing of drugs and medications. Investing in pharmaceutical stocks offers individuals an opportunity to participate in this ever-evolving sector.

The pharmaceutical industry can be categorised into various segments, including biotechnology , generic drugs and specialty pharmaceuticals. Each segment has its unique characteristics and investment opportunities.

1. Biotechnology: This segment of the pharmaceutical industry involves the use of living organisms or their components to develop and manufacture drugs. Biotechnology companies focus on research and development of drugs derived from biological sources, such as vaccines, gene therapies and monoclonal antibodies. BioNTech and Novo Nordisk are considered biotechnology companies.
2. Generic drugs: Generic drugs are copies of brand-name drugs that have lost their patent protection. Generic pharmaceutical companies produce these drugs after the patent expires, allowing them to manufacture and sell the same drug at a lower cost. This segment plays a crucial role in providing affordable alternatives to expensive brand-name drugs. Some examples are Teva Pharmaceuticals and Sandoz.
3. Specialty pharmaceuticals: Specialty pharmaceuticals refer to medications that are used to treat complex or chronic conditions, typically requiring specialised handling, administration or monitoring. These drugs are often expensive and may require special storage conditions or administration methods, such as injectables or infusions. Examples in this segment include Sanofi and Novartis.

Examples of pharmaceutical stocks

Here are a few examples of well-known companies in the pharmaceutical industry:

1. Pfizer Inc. (NYSE: PFE): Pfizer is one of the largest pharmaceutical companies globally and is known for its innovative research and development. It has a diverse portfolio of drugs, ranging from vaccines to treatments for various diseases. One of Pfizer's most notable products is the Covid-19 vaccine Comirnaty, which made the company a key player in combatting the virus.
2. Johnson & Johnson (NYSE: JNJ): Known for its diverse healthcare products portfolio, Johnson & Johnson operates not only in the pharmaceutical segment but also in medical devices and consumer health.
3. Novartis AG (NYSE: NVS): Novartis is a Swiss multinational company specialising in research-based medicines, with a strong presence in both branded prescription drugs and generic medications. Some of its main areas of focus are on cardiovascular health, immunology, neuroscience and oncology.
4. Merck & Co., Inc. (NYSE: MRK): Merck is a leading global healthcare company that develops innovative prescription drugs alongside vaccines and animal health products. Examples of products in its portfolio include the leading cancer drug Keytruda and the HPV vaccine Gardasil.
5. Gilead Sciences Inc. (NASDAQ: GILD): Gilead Sciences primarily focuses on antiviral drugs used to treat HIV/AIDS, hepatitis C, influenza and other infectious diseases. The company is well known for its pre-exposure prophylaxis (PrEP) medicines Truvada and Descovy, which are preventative HIV medications. In addition to these, the company plans to launch five new HIV products by 2030.

Pros & cons of investing in pharmaceutical stocks

Like any investment, there are advantages and disadvantages of investing in pharmaceutical stocks. Here are a few you may want to consider:

Pros of pharmaceutical stocks

• Innovation and growth potential: The pharmaceutical sector is known for continuous innovation, driven by research and development efforts. Successful drug discoveries can generate substantial profits for companies.
• High global demand: Pharmaceuticals are essential products with a consistent demand worldwide. As the global population grows and ages, the need for medications is expected to increase.
• Defensive investment: Including pharmaceutical stocks in an investment portfolio can provide diversification benefits due to the sector's relatively low correlation with other industries.
• Dividend potential: Many established pharmaceutical companies offer regular dividend payments to shareholders, providing a potential income stream.

Cons of pharmaceutical stocks

• Regulatory challenges: The pharmaceutical industry faces strict regulations from government bodies such as the Food and Drug Administration (FDA). Adverse regulatory decisions or delays in drug approvals can significantly impact stock prices.
• Patent expirations: Patents protecting drugs eventually expire, allowing generic versions to enter the market at lower prices. This patent cliff can lead to decreased revenues for companies unless they have a robust pipeline of new drugs under development.
• Clinical trials risk: The success of a pharmaceutical company often hinges on the results of clinical trials. Negative trial outcomes or safety concerns can cause significant stock price declines.
• Competitive landscape: The industry is highly competitive, with numerous players vying for market share within therapeutic areas. Intense competition may affect pricing power and profitability.

Investing in pharmaceutical ETFs

If you are interested in a diversified basket of pharmaceutical stocks without directly investing in individual companies, pharmaceutical ETFs can be a viable option. These funds track pharmaceutical sector indices and offer investors an opportunity to participate in the industry's overall performance.

Pharmaceutical ETFs provide access to a diversified portfolio of pharmaceutical stocks. They also offer liquidity and transparency, as their prices are continuously quoted throughout market hours. Here’s a pharma ETF we offer on our platform:

Note: This ETF may not be available on our platform for your country (temporarily) due to regulatory reasons.